| Similar Articles |
|---|
 |
The Motley Fool
February 1, 2008
Brian Lawler |
Credit Crisis Bites Big Pharma Bristol-Myers Squibb takes a $275 million writedown in its investment portfolio for the quarter.   |
Chemistry World
April 4, 2013
Phillip Broadwith |
Amylin headquarters to close with further job losses Bristol-Myers Squibb has confirmed that it will be closing the site in San Diego, US, which was formerly the corporate headquarters of biotech firm Amylin. |
BusinessWeek
September 27, 2004
Kerry Capell |
How Dublin Keeps Big Pharma Happy By providing cheap yet educated workers and giving tax breaks to big investors, the Irish have turned their country into a major drug manufacturing center. |
Bio-IT World
April 2006
Samara McCarthy |
Ireland's Biotech Boom How the Emerald Isle has made its name in the life sciences. |
Chemistry World
November 3, 2015
Phillip Broadwith |
Bristol-Myers Squibb to buy Cardioxyl for heart drug The deal gives BMS full rights to develop CXL-1427, an experimental drug for acute decompensated heart failure, currently in Phase II clinical trials. |
IndustryWeek
April 18, 2012 |
Plant Managers Assume More Profit-Driving Responsibilities In today's fast-paced, globalized economy companies are seeking plant managers with a strong business sense. |
IndustryWeek
May 20, 2009
Jonathan Katz |
Ford Plant Restarts Engines With Skilled Training Cleveland Engine Plant No. 1 used lean manufacturing and new cultural practices that helped the plant gain a new engine. |
Chemistry World
October 7, 2015
Phillip Broadwith |
Bristol-Myers-Squibb fined for alleged Chinese bribes The US Securities and Exchange Commission has fined New York based pharmaceutical company Bristol-Myers Squibb over $14 million over alleged bribes made to Chinese state owned hospitals. |
American Family Physician
February 15, 2002 |
Burning Mouth Syndrome What is burning mouth syndrome?... What causes BMS?... How can my doctor tell if I have BMS?... How is BMS usually treated?... |
The Motley Fool
May 12, 2005
Stephen D. Simpson |
Should You Bank on Ireland? Bank of Ireland is doing fine, but it may not be the best stock pick on the Emerald Isle. |
Chemistry World
June 5, 2015
Rebecca Trager |
BMS sues executive for joining rival company Bristol-Myers Squibb has filed a lawsuit against a former executive who quit suddenly last month to work for a direct competitor, AstraZeneca. |
The Motley Fool
September 7, 2010
Gerard Torres |
Sovereign Debt Crisis Continued: Irish Banks The downgrade of Ireland's credit rating has a large impact on Irish banks. |
The Motley Fool
April 18, 2011
Zeeshan Siddique |
What Can We Learn From Bank of Ireland's Shrinking Loss? Bank of Ireland betters its performance. But is it good enough? |
Food Engineering
August 3, 2006
Joyce Fassl |
Editor's Note: In search of the next winner Which outstanding new plant construction project, major expansion or highly renovated facility will be the next Plant of the Year? |
Chemistry World
January 11, 2016
Phillip Broadwith |
GSK's ViiV to buy HIV drugs from BMS Bristol-Myers Squibb has agreed to sell its entire portfolio of investigational HIV drugs as the company seeks to exit research in virology. |
Chemistry World
September 12, 2011
Andrew Turley |
Ireland Still Attractive to Pharma Industry The drug industry is still keen to invest in Ireland. |
IndustryWeek
December 16, 2009 |
General Cable Corp. - Altoona Plant: IW Best Plants Profile 2009 Competing With the World: With savvy market moves and a passion for continuous improvement, the General Cable Altoona plant is meeting the competition head on and winning. |
Chemistry World
December 20, 2013
Patrick Walter |
AstraZeneca shells out $4.1bn for diabetes business AstraZeneca has agreed to pay Bristol-Myers Squibb up to $4.1 billion for its share of the pharma giants' diabetes joint venture. |
Chemistry World
April 9, 2015
Emma Stoye |
BMS invests in gene therapy Bristol-Myers Squibb has agreed to invest over $100 million in Netherlands-based biotechnology company uniQure, which specializes in gene therapies for cardiovascular diseases. |
Chemistry World
July 8, 2014
Phillip Broadwith |
First of a new breed of anticancer antibodies approved in Japan Ono pharmaceuticals' Opdivo (nivolumab) has been approved for treating melanomas where surgery is impossible. |
Food Processing
March 2012 |
MRO Q&A: Assigning Numbers to Maintenance What is a reasonable ratio of plant maintenance expense to plant sales output? |
InternetNews
October 16, 2009 |
IBM Ramps Up Analytics Research Abroad IBM teams up with Ireland's IDA to develop advanced risk analytics technologies. |
The Motley Fool
April 5, 2011
Zeeshan Siddique |
Can Bank of Ireland Dodge This Bullet Yet Again? After failing a stress test, Bank of Ireland struggles retaining its independence. |
Food Processing
May 2005
Mike Pehanich |
How to retrofit an aging plant Food processors looking to retrofit aging facilities to get more out of their capital budgets should heed these "rules of retro" before they bring their plants into the 21st century. |
Pharmaceutical Executive
June 1, 2013 |
Country Report: Ireland Ireland has been a pharma industry darling since the 1960s, when a then-newly established IDA targeted the sector as a strategic area for development. Today, the numbers are eye catching. |
Pharmaceutical Executive
August 1, 2005
Joanna Breitstein |
Weathering the Storm Out from financial scandal, CEO Peter Dolan is steering Bristol-Myers Squibb's most productive pipeline yet. |
